Oculis is a clinical stage biopharmaceutical company whose mission is to develop novel topical treatments (eye drops) for ophthalmic diseases for both back-and front-of-the-eye in order to improve the sight and the lives of patients worldwide.

Biotechnology

Oculis

Oculis' headquarters in Lausanne, Switzerland

Riad Sherif

Sylvia Cheung

Sharon Klier

Petra Egger

Rebecca W.

Rebecca Weil

Gudrun Bachmann

David Jacobs

Páll Ragnar Jóhannesson

Lionel Carnot

Sylvia He

Vanessa Huang

Eric Donnenfeld

Sabri Markabi

Pablo Villoslada

Christophe Baudouin

Peter K. Kaiser

Anat Loewenstein

Arshad M. Khanani

Pravin Dugel

Quan Dong Nguyen

Ramin Tadayoni

Geraldine O’Keeffe

Martijn Kleijwegt

Christina Ackermann

Einar Stefánsson

Anthony Rosenberg

The Scientific Advisors and Research Scientists team at Oculis plays a pivotal role in advancing the company's mission by providing expert guidance and innovative solutions for the development of novel ophthalmic treatments. This team collaborates on research design, formulates eye drop therapies, and conducts rigorous scientific evaluations to optimize product efficacy and safety, ensuring that Oculis delivers cutting-edge therapies to improve patient outcomes.

Scientific Advisors and Research Scientists

The Leadership Team at Oculis is responsible for setting the strategic direction and vision of the company, guiding the development of innovative ophthalmic treatments, and ensuring effective resource allocation. They collaborate across functional areas, oversee key operational initiatives, and drive strategic partnerships to enhance business growth and patient outcomes in the ophthalmic healthcare market.

Leadership Team

The Financial Management and Analysis team at Oculis is responsible for overseeing the company’s financial health and strategic planning. They manage budgeting, forecasting, and financial reporting, ensuring that resources are allocated efficiently to support the development of innovative ophthalmic treatments. This team plays a critical role in guiding decision-making and maintaining compliance, ultimately contributing to Oculis's mission of enhancing patient outcomes through advanced therapies.

Financial Management and Analysis

The Clinical Operations and Development team at Oculis is responsible for overseeing the planning and execution of clinical trials for innovative ophthalmic therapies. They collaborate with regulatory affairs to ensure compliance, manage the development process from conception to clinical validation, and coordinate cross-functional teams to drive the progression of projects aimed at enhancing patient outcomes.

Clinical Operations and Development

Oculis

Org chart

Board & advisors

Teams

Scientific Advisors and Research Scientists

Leadership Team

Financial Management and Analysis

Clinical Operations and Development

Offices

Oculis

Org chart

Board & advisors

Teams

Scientific Advisors and Research Scientists

Leadership Team

Financial Management and Analysis

Clinical Operations and Development

Offices

Related companies